COMMUNIQUÉS West-GlobeNewswire

UroGen Pharma Expands Clinical Development Leadership Team

12/12/2017 - 14:30

Mark Schoenberg, M.D., Named Chief Medical Officer Elyse Seltzer, M.D., Appointed Senior Vice President of Clinical Development RA'ANANA, Israel and NEW YORK, Dec. 12, 2017 (GLOBE NEWSWIRE) -- UroGen Pharma Ltd. (NASDAQ [...]

Rockwell Medical Signs Exclusive License Agreement with Quimica Europea to Commercialize Triferic® in Peru

12/12/2017 - 14:30

- Estimated Market Launch 2 nd -half 2018 Provides Access to 13,000 Dialysis Patients - WIXOM, Mich., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (NASDAQ: RMTI ), announced today that it has signed an [...]

Portola Pharmaceuticals Provides Update on European Marketing Authorization Application for Betrixaban

12/12/2017 - 14:30

South San Francisco, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Portola Pharmaceuticals, Inc. ® (Nasdaq: PTLA ) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines [...]

Roy Davis Joins Liquid Biopsy Company Clinical Genomics Board of Directors

12/12/2017 - 14:30

BRIDGEWATER, N.J., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Clinical Genomics, a leading provider of cancer diagnostic solutions including liquid biopsy tests, today announced the appointment of Roy Davis as Senior Advisor and [...]

Onconova Presents Data on Rigosertib in Myelodysplastic Syndromes (MDS) at the ASH 2017 Meeting

12/12/2017 - 14:30

Oral rigosertib as a single agent demonstrates activity in a Phase 2 trial for lower-risk MDS 32% of 62 evaluable patients, and 44% of patients receiving optimal dosing, achieved transfusion independence New data on the [...]

assessURhealth, LLC Partners with athenahealth’s ‘More Disruption Please’ Program to Enhance Access to Mental and Behavioral Health Screening Tools

12/12/2017 - 14:01

Tampa, FL, Dec. 12, 2017 (GLOBE NEWSWIRE) -- assessURhealth, LLC , a provider of mental and behavioral health screening software, today announced a partnership with athenahealth , Inc. through athenahealth’s ‘ More [...]

scPharmaceuticals Inc. to Present at the BMO Capital Markets Prescriptions for Success Healthcare Conference

12/12/2017 - 14:00

BURLINGTON, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- scPharmaceuticals Inc. (Nasdaq: SCPH ), a pharmaceutical company focused on developing and commercializing products that have the potential to transform infused [...]

Two Centers from The US Oncology Network Adopt iCAD’s Xoft Electronic Brachytherapy System for Treatment of Early-Stage Non-Melanoma Skin Cancer

12/12/2017 - 14:00

Prominent cancer centers expand portfolio of patient-centric treatment solutions with Xoft’s innovative, painless, scar-free solution NASHUA, N.H., Dec. 12, 2017 (GLOBE NEWSWIRE) -- iCAD, Inc. (NASDAQ: ICAD ), a global [...]

New York eHealth Collaborative Selects HealthEC to Provide MIPS Reporting through its Qualified Clinical Data Registry Services

12/12/2017 - 14:00

PISCATAWAY, N.J., Dec. 12, 2017 (GLOBE NEWSWIRE) -- HealthEC today announced that it has been selected by the New York eHealth Collaborative (NYeC) to customize its Merit-based Incentive Payment System (MIPS) reporting [...]

VBI Vaccines to Present at the BMO Capital Markets 2017 Prescriptions for Success Healthcare Conference

12/12/2017 - 14:00

CAMBRIDGE, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- VBI Vaccines Inc. (Nasdaq: VBIV ) (TSX: VBV ) (VBI) today announced that Jeff Baxter, President and CEO, will present at the BMO Capital Markets Prescriptions for [...]

Aduro Biotech Provides Update on CRS-207 Programs

12/12/2017 - 14:00

BERKELEY, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (Nasdaq: ADRO ), a biopharmaceutical company with three distinct immunotherapy technologies, today provided an update on its clinical development [...]

Ohr Pharmaceutical to Announce Fiscal Fourth Quarter & Year End 2017 Results on Friday, December 15

12/12/2017 - 14:00

NEW YORK, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Ohr Pharmaceutical, Inc. (Nasdaq: OHRP ), a clinical-stage pharmaceutical company developing novel therapies for ophthalmic diseases, today announced that it will report [...]

Mersana Announces First Patient Dosed with XMT-1536 in Phase 1 Study in Patients with NaPi2b-Expressing Tumors

12/12/2017 - 14:00

Trial to Study Patients in Ovarian, NSCLC and Other Cancers XMT-1536 is Second Dolaflexin Antibody Drug Conjugate to Enter Clinical Trials CAMBRIDGE, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. ( [...]

Innovation Pharmaceuticals Granted European Patent for Brilacidin in the Prevention of Oral Mucositis

12/12/2017 - 14:00

BEVERLY, Mass., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Innovation Pharmaceuticals, (OTCQB:IPIX) (“the Company”), a clinical stage biopharmaceutical company, announced today that the European Patent Office has granted a [...]

ABLYNX REPORTS ADDITIONAL CLINICALLY IMPORTANT BENEFITS OF CAPLACIZUMAB FROM ITS PHASE III HERCULES STUDY IN ACQUIRED TTP

12/12/2017 - 13:41

Additional results from the Phase III HERCULES study showed that treatment with caplacizumab resulted in: 38% relative reduction in the number of days of plasma exchange (PEX) 41% relative reduction in the volume of [...]

Corium to Join NASDAQ Biotechnology Index

12/12/2017 - 13:30

MENLO PARK, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE) -- Corium International, Inc. (Nasdaq: CORI ), a commercial-stage biopharmaceutical company focused on the development, manufacture and commercialization of specialty [...]

Geron Reports Imetelstat Presentations at American Society of Hematology Annual Meeting

12/12/2017 - 13:30

Imetelstat Clinical Data from Part 1 of IMerge in Myelodysplastic Syndromes (MDS) Presented Analyst and Investor Meeting and Webcast at 8:30 a.m. ET on December 19, 2017 MENLO PARK, Calif., Dec. 12, 2017 (GLOBE NEWSWIRE [...]

Actinium Pharmaceuticals Highlights Promising Data From its AWE Program Featuring a Potent Actinium-225 Labeled Daratumumab Labeled ARC or Antibody Radio-Conjugate Presented at ASH Annual Meeting

12/12/2017 - 13:30

Higher cell death observed with Actinium-225 labeled daratumumab with up to ten-fold higher potency as compared to naked daratumuamb ARC of Daratumumab-Actinium-225 labeled with high yield, high stability and preserved [...]

Nature’s Recent Scientific Reports Publication Describes How Apabetalone May Be a Powerful Agent Against HIV-1

12/12/2017 - 13:30

CALGARY, Alberta, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. (“Resverlogix” or the “Company”) (TSX: RVX ) announced today that a recent Nature Scientific Reports has published a 12 page publication on BET ( [...]